Breaking News, Collaborations & Alliances

Catalent Licenses CR Tableting Tech from Sanwa

OSDrC delivery tech adds to Catalent's oral solid dosage offerings

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Catalent Pharma Solutions and Sanwa Kagaku Kenkyusho Co., Ltd. have entered into an exclusive agreement to bring OSDrC, Sanwa’s drug delivery tableting technology, to global markets. Catalent will market OSDrC in all markets outside of Japan, Korea, China (Hong Kong), and Taiwan. OSDrC is a fully developed, optimized, dose delivery technology that has commercially marketed by Sanwa in Japan. Catalent will utilize its global footprint, modified release delivery expertise, and integrated manufact...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters